Akech et al. [148] also detected that prostate cancer overexpression of RUNX2 activated genes necessary for metastasis and invasion (MMP2, MMP9, MMP13), angiogenesis (VEGF, osteopontin), and survival (survivin). This evidence concerns the gene RUNX2 and Familial prostate cancer.